NEUROENDOCRINE CARCINOMA OF PROSTATE

This adverse event was reported 68 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE CARCINOMA OF PROSTATE:

# Drug Count
0 DOCETAXEL 22
1 DOCETAXEL ANHYDROUS 22
2 LEUPROLIDE ACETATE 17
3 ETOPOSIDE 15
4 ABIRATERONE ACETATE 12
5 BICALUTAMIDE 12
6 ABIRATERONE 9
7 CARBOPLATIN 8
8 DAROLUTAMIDE 8
9 PACLITAXEL 8
See all common drugs associated with NEUROENDOCRINE CARCINOMA OF PROSTATE

NEUROENDOCRINE CARCINOMA OF PROSTATE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DAROLUTAMIDE 8 0.0014
1 LAROTRECTINIB 1 0.0011
2 CABAZITAXEL 3 0.0009
3 BICALUTAMIDE 12 0.0008
4 DEGARELIX 4 0.0008
5 TRIPTORELIN 2 0.0006
6 DOCETAXEL 22 0.0003
7 DOCETAXEL ANHYDROUS 22 0.0003
8 ABIRATERONE ACETATE 12 0.0003
9 LEUPROLIDE ACETATE 17 0.0002
See all drugs enriched for association with NEUROENDOCRINE CARCINOMA OF PROSTATE